Skip to content
Back to Guavy Wire
Stocks

Amgen Hacked: Patient Data, IP Potentially Stolen

Instruments
AMGN
Share

Biotech firm Amgen has notified US regulators about a data exfiltration hack that may have exposed patient information and intellectual property. The company, which reported nearly $37 billion in revenue in fiscal 2025, said it detected unauthorized activity in July involving data stored in cloud environments hosted by third-party providers.

Amgen's filing with the SEC states that the company has since learned some of its data, including proprietary information and patient protected health information, has been exfiltrated from these cloud environments. The incident is deemed 'material' due to the volume of files potentially compromised and the types of information contained.

The hack bears similarities to recent attacks on healthcare companies by the ShinyHunters gang, which has carried out a wave of cloud-scale data exfiltration in the sector. Experts say that while the cloud is not inherently less secure, successful attacks can have a broader impact due to data storage practices.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment advisor. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Real-time market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc